FindTrial
Sign In

Noxafil 300 mg concentrate for solution for infusion

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC, Centre Hospitalier Universitaire De Nantes

Conditions

30 adult patients due to receive an allograft for a myeloid or lymphoid hematological malignancy with an HLA-matched donor from the family or from the international donor file will be included in the hematology departments of the Nantes University Hospital.Fungal infection

Phase 2

A Phase 2, Open-Label, Single-Arm, Sequential-Panel Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Posaconazole (POS, MK-5592) Intravenous and Powder for Oral Suspension Formulations in Pediatric Participants From Birth to Less Than 2 Years of Age With Possible, Probable, or Proven Invasive Fungal Infection
RecruitingCTIS2023-505613-24-00
Merck Sharp & Dohme LLCFungal infection
Start: 2021-04-28Target: 13Updated: 2025-08-19
Study of posaconazole prophylaxis in patients receiving hematopoietic stem cell allograft (allo-HSC) at high risk of invasive fungal infection (IFI): POSALLO study
RecruitingCTIS2024-511507-42-00
Centre Hospitalier Universitaire De Nantes30 adult patients due to receive an allograft for a myeloid or lymphoid hematological malignancy with an HLA-matched donor from the family or from the international donor file will be included in the hematology departments of the Nantes University Hospital.
Start: 2024-11-08Target: 30Updated: 2024-07-23